The insulinogenic effect of whey protein is partially mediated by a direct effect of amino acids and GIP on β-cells

Albert Salehi, Ulrika Gunnerud, Sarheed J Muhammed, Elin Ostman, Jens J Holst, Inger Björck, Patrik Rorsman, Albert Salehi, Ulrika Gunnerud, Sarheed J Muhammed, Elin Ostman, Jens J Holst, Inger Björck, Patrik Rorsman

Abstract

Background: Whey protein increases postprandial serum insulin levels. This has been associated with increased serum levels of leucine, isoleucine, valine, lysine, threonine and the incretin hormone glucose-dependent insulinotropic polypeptide (GIP). We have examined the effects of these putative mediators of whey's action on insulin secretion from isolated mouse Langerhans islets.

Methods: Mouse pancreatic islets were incubated with serum drawn from healthy individuals after ingestion of carbohydrate equivalent meals of whey protein (whey serum), or white wheat bread (control serum). In addition the effect of individual amino acid combinations on insulin secretion was also tested. Furthermore, the stimulatory effects of whey serum on insulin secretion was tested in vitro in the absence and presence of a GIP receptor antagonist ((Pro(3))GIP[mPEG]).

Results: Postprandial amino acids, glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide 1 (GLP-1) responses were higher after whey compared to white wheat bread. A stimulatory effect on insulin release from isolated islets was observed with serum after whey obtained at 15 min (+87%, P < 0.05) and 30 min (+139%, P < 0.05) postprandially, compared with control serum. The combination of isoleucine, leucine, valine, lysine and threonine exerted strong stimulatory effect on insulin secretion (+270%, P < 0.05), which was further augmented by GIP (+558% compared to that produced by glucose, P < 0.05). The stimulatory action of whey on insulin secretion was reduced by the GIP-receptor antagonist (Pro(3))GIP[mPEG]) at both 15 and 30 min (-56% and -59%, P < 0.05).

Conclusions: Compared with white wheat bread meal, whey causes an increase of postprandial insulin, plasma amino acids, GIP and GLP-1 responses. The in vitro data suggest that whey protein exerts its insulinogenic effect by preferential elevation of the plasma concentrations of certain amino acids, GIP and GLP-1.

Figures

Figure 1
Figure 1
Amino acid responses in humans. Mean (± SEM) values of isoleucine, leucine, valine, lysine and threonine in plasma obtained at different time points in response to the whey (▴) and WWB (■) meal.
Figure 2
Figure 2
Incretin responses in humans. Mean (± SEM) values of GIP (A) and GLP-1 (B) in plasma obtained at different time points in response to the whey (▲) and WWB (■) meal.
Figure 3
Figure 3
Insulin secretion of Langerhans islets incubated with human serum. Insulin secretion of isolated pancreatic islets incubated with serum obtained from healthy subjects after ingestion of whey (grey bars) and WWB (control, white bars), and 8.3 mM glucose alone (reference, black bar). The islets were pooled from 8 different NMRI mice and values are means ± SEM for 10 observations in each group performed at three different occasions. Significant differences between whey and control serum for each time point are denoted by **P < 0.01, ***P < 0.001.
Figure 4
Figure 4
Insulin secretion of Langerhans islets incubated with amino acid. Insulin secretion from isolated pancreatic islets incubated at 8.3 mM glucose in the absence or presence of leucine, isoleucine, valine, lysine and threonine, a cocktail of the 5 amino acids or a cocktail + GIP. Values are means ± SEM for 8 observation in each group performed at three different occasions. The experiments were performed on the islets isolated and pooled from 6 different NMRI mice. Values with different letters are significantly different, P < 0.05.
Figure 5
Figure 5
Insulin secretion of Langerhans islet incubated with human serum in presence of a GIP-receptor antagonist. Insulin secretion from isolated mice pancreatic islets incubated at 8.3 mmol/l glucose + whey serum (obtained before intake time 0 as well as at 15 and 30 min after meal ingestion) in the absence (white bars) and presence (black bars) of GIP-receptor antagonist ((Pro(3))GIP[mPEG]) (100 nmol/l). Values are means ± SEM for 8 observations in each group performed at three different occasions on the isolated islets from 6 different NMRI mice. Significant differences between absence and presence of the antagonist are denoted by * P < 0.05; * * P < 0.005.

References

    1. Östman EM, Liljeberg Elmståhl HGM, Björck IME. Inconsistency between glycemic and insulinemic responses to regular and fermented milk products. Am J Clin Nutr. 2001;74:96–100.
    1. Nilsson M, Elmstahl H, Bjorck I. Glucose and insulin responses to porridge and gruel meals intended for infants. Eur J Clin Nutr. 2005;59:646–650. doi: 10.1038/sj.ejcn.1602115.
    1. Liljeberg Elmståhl H, Björck I. Milk as a supplement to mixed meals may elevate postprandial insulinaemia. Eur J Clin Nutr. 2001;55:994–999. doi: 10.1038/sj.ejcn.1601259.
    1. Nilsson M, Stenberg M, Frid AH, Holst JJ, Björck IM. Glycemia and insulinemia in healthy subjects after lactose-equivalent meals of milk and other food proteins: the role of plasma amino acids and incretins. Am J Clin Nutr. 2004;80:1246–1253.
    1. Khan MA, Gannon MC, Nuttall FQ. Glucose appearance rate following protein ingestion in normal subjects. J Am Coll Nutr. 1992;11:701–706.
    1. Nilsson M, Holst JJ, Bjorck IME. Metabolic effects of amino acid mixtures and whey protein in healthy subjects: studies using glucose-equivalent drinks. Am J Clin Nutr. 2007;85:996–1004.
    1. Krebs M, Brehm A, Krssak M, Anderwald C, Bernroider E, Nowotny P, Roth E, Chandramouli V, Landau BR, Waldhausl W, Roden M. Direct and indirect effects of amino acids on hepatic glucose metabolism in humans. Diabetologia. 2003;46:917–925. doi: 10.1007/s00125-003-1129-1.
    1. Fajans SS, Floyd JC, Knopf RF, Conn FW. Effect of amino acids and proteins on insulin secretion in man. Recent Prog Horm Res. 1967;23:617–662.
    1. Floyd JC, Fajans SS, Conn JW, Knopf RF, Rull J. Stimulation of insulin secretion by amino acids. J Clin Invest. 1966;45:1487–1502. doi: 10.1172/JCI105456.
    1. Schmid R, Schusdziarra V, Schulte-Frohlinde E, Maier V, Classen M. Role of amino acids in stimulation of postprandial insulin, glucagon, and pancreatic polypeptide in humans. Pancreas. 1989;4:305–314. doi: 10.1097/00006676-198906000-00006.
    1. Schmid R, Schulte-Frohlinde E, Schusdziarra V, Neubauer J, Stegmann M, Maier V, Classen M. Contribution of postprandial amino acid levels to stimulation of insulin, glucagon, and pancreatic polypeptide in humans. Pancreas. 1992;7:698–704. doi: 10.1097/00006676-199211000-00011.
    1. Van Loon LJ, Kruijshoop M, Menheere PP, Wagenmakers AJ, Saris WH, Keizer HA. Amino Acid ingestion strongly enhances insulin secretion in patients with long-term type 2 diabetes. Diabetes Care. 2003;26:625–630. doi: 10.2337/diacare.26.3.625.
    1. Gannon MC, Nuttall FQ. Amino acid ingestion and glucose metabolism—A review. IUBMB Life. 2010;62:660–668. doi: 10.1002/iub.375.
    1. Frid AH, Nilsson M, Holst JJ, Bjorck IME. Effect of whey on blood glucose and insulin responses to composite breakfast and lunch meals in type 2 diabetic subjects. Am J Clin Nutr. 2005;82:69–75.
    1. Stenberg M, Marko-Varga G, Oste R. Enantioseparation of d- and l-amino acids by a coupled system consisting of an ion-exchange column and a chiral column and determination of d-aspartic acid and d-glutamic acid in soy products. Food Chem. 2002;79:507–512. doi: 10.1016/S0308-8146(02)00215-7.
    1. Krarup T, Madsbad S, Moody AJ, Regeur L, Faber OK, Holst JJ, Sestoft L. Diminished immunoreactive gastric inhibitory polypeptide response to a meal in newly diagnosed type I (insulin-dependent) diabetics. J Clin Endocrinol Metab. 1983;56:1306–1312. doi: 10.1210/jcem-56-6-1306.
    1. Orskov C, Rabenhoj L, Wettergren A, Kofod H, Holst JJ. Tissue and plasma concentrations of amidated and glycine-extended glucagon-like peptide I in humans. Diabetes. 1994;43:535–539. doi: 10.2337/diabetes.43.4.535.
    1. Salehi A, Chen D, Hakanson R, Nordin G, Lundquist I. Gastrectomy induces impaired insulin and glucagon secretion: evidence for a gastro-insular axis in mice. J Physiol. 1999;514(Pt 2):579–591.
    1. Salehi A, Vieira E, Gylfe E. Paradoxical Stimulation of Glucagon Secretion by High Glucose Concentrations. Diabetes. 2006;55:2318–2323. doi: 10.2337/db06-0080.
    1. Lundquist I, Panagiotidis G, Salehi A. Islet acid glucan-1,4-alpha-glucosidase: a putative key enzyme in nutrient-stimulated insulin secretion. Endocrinology. 1996;137:1219–1225. doi: 10.1210/en.137.4.1219.
    1. Panagiotidis G, Salehi AA, Westermark P, Lundquist I. Homologous islet amyloid polypeptide: effects on plasma levels of glucagon, insulin and glucose in the mouse. Diabetes Res Clin Pract. 1992;18:167–171. doi: 10.1016/0168-8227(92)90142-E.
    1. Jimenez-Feltstrom J, Salehi A, Meidute Abaraviciene S, Henningsson R, Lundquist I. Abnormally decreased NO and augmented CO production in islets of the leptin-deficient ob/ob mouse might contribute to explain hyperinsulinemia and islet survival in leptin-resistant type 2 obese diabetes. Regul Pept. 2011;170:43–51. doi: 10.1016/j.regpep.2011.04.011.
    1. Trümper A, Trümper K, Trusheim H, Arnold R, Göke B, Hörsch D. Glucose-Dependent Insulinotropic Polypeptide Is a Growth Factor for β (INS-1) Cells by Pleiotropic Signaling. Mol Endocrinol. 2001;15:1559–1570. doi: 10.1210/me.15.9.1559.
    1. Asmar M, Holst JJ. Glucagon-like peptide 1 and glucose-dependent insulinotropic polypeptide: new advances. Curr Opin Endocrinol Diabetes Obes. 2010;17:57–62.
    1. Yabe D, Seino Y. Two incretin hormones GLP-1 and GIP: Comparison of their actions in insulin secretion and [beta] cell preservation. Prog Biophys Mol Biol. In Press, Corrected Proof.
    1. Veldhorst MAB, Nieuwenhuizen AG, Hochstenbach-Waelen A, van Vught AJAH, Westerterp KR, Engelen MPKJ, Brummer R-JM, Deutz NEP, Westerterp-Plantenga MS. Dose-dependent satiating effect of whey relative to casein or soy. Physiol Behav. 2009;96:675–682. doi: 10.1016/j.physbeh.2009.01.004.
    1. Ronner P, Naumann CM, Friel E. Effects of glucose and amino acids on free ADP in betaHC9 insulin-secreting cells. Diabetes. 2001;50:291–300. doi: 10.2337/diabetes.50.2.291.
    1. Zander M, Madsbad S, Madsen JL, Holst JJ. Effect of 6-week course of glucagon-like peptide 1 on glycaemic control, insulin sensitivity, and beta-cell function in type 2 diabetes: a parallel-group study. Lancet. 2002;359:824–830. doi: 10.1016/S0140-6736(02)07952-7.
    1. Solerte SB, Fioravanti M, Locatelli E, Bonacasa R, Zamboni M, Basso C, Mazzoleni A, Mansi V, Geroutis N, Gazzaruso C. Improvement of Blood Glucose Control and Insulin Sensitivity During a Long-Term (60 Weeks) Randomized Study with Amino Acid Dietary Supplements in Elderly Subjects with Type 2 Diabetes Mellitus. Am J Cardiol. 2008;101:S82–S88.
    1. Solerte SB, Gazzaruso C, Bonacasa R, Rondanelli M, Zamboni M, Basso C, Locatelli E, Schifino N, Giustina A, Fioravanti M. Nutritional Supplements with Oral Amino Acid Mixtures Increases Whole-Body Lean Mass and Insulin Sensitivity in Elderly Subjects with Sarcopenia. Am J Cardiol. 2008;101:S69–S77.
    1. Boirie Y, Dangin M, Gachon P, Vasson M-P, Maubois J-L, Beaufrére B. Slow and fast dietary proteins differently modulate postprandial protein accretion. Proc Natl Acad Sci. 1997;94:14930–14935. doi: 10.1073/pnas.94.26.14930.
    1. Calbet JA, Holst JJ. Gastric emptying, gastric secretion and enterogastrone response after administration of milk proteins or their peptide hydrolysates in humans. Eur J Nutr. 2004;43:127–139. doi: 10.1007/s00394-004-0448-4.

Source: PubMed

3
Prenumerera